Shares of ResMed Inc. RMD slid 3.83% to $205.17 Friday, on what proved to be an all-around dismal trading session for the ...

The home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea ...

Leading health technology, Resmed, has announced its home sleep apnea test, NightOwl, is now available across the United ...

RMD recently launched its home sleep apnea test, NightOwl, across the United States. NightOwl is an FDA-cleared home sleep apnea test (HSAT), designed to offer healthcare providers a simplified, ...

Let's see which of these two names could be best buys. The post Should I buy Fisher & Paykel or ResMed shares? appeared first ...

Donald Trump described Liberation Day as such because the tariffs will “end the decades of unfair trade practices that have ...

By examining financial metrics, experts have insights into where the Australian healthcare market is today and where it might ...

US President Donald Trump’s “liberation day” tariffs have rattled global markets. Since the pronouncement, the Australia ...

In a report released today, David Bailey from Morgan Stanley maintained a Hold rating on Ansell (ANSLF – Research Report), with a price target ...

A new Resmed-supported study showing sleep apnea patients on CPAP therapy live longer will further fuel a “once-in-a-generation opportunity” to increase awareness, says Carlos Nunez, ...

Once considered a secondary option to hospital-based treatment, industry experts say home respiratory care has now become the standard for managing chronic conditions.

The world's leading CPAP manufacturer has been caught up in the tech and healthcare selloff, but the long-term growth story ...